Legal Opinion
Amphastar Pharm., Inc. v. Momenta Pharm., Inc.
District Court, District of Columbia
Decided March 19, 2018No. Civil Action No. 16–10112–NMGPublishedCited by 4 opinions
1Opinion of the Court
GORTON, District Judge.
*225This is an antitrust case in which plaintiffs Amphastar Pharmaceuticals, Inc. ("Amphastar Pharmaceuticals") and International Medication Systems, Ltd. ("IMS")(collectively, "Amphastar" or "plaintiffs") allege that defendants Momenta Pharmaceuticals, Inc. ("Momenta Pharmaceuticals") and Sandoz Inc. ("Sandoz")(collectively, "Momenta" or "defendants") restricted trade and prevented competition in the manufacture and sales of the generic drug enoxaparin.
Pending before the Court is Momenta's motion to dismiss the complaint (Docket No. 17), which will be treated as a motion…
2Cases cited22 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Ocasio-Hernandez v. Fortuno-BursetCourt of Appeals for the First Circuit · 2011
- Monsanto Co. v. Spray-Rite Service Corp.Supreme Court of the United States · 1984
- Haley v. City of BostonCourt of Appeals for the First Circuit · 2011
17 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Bio-Rad Laboratories, Inc. v. 10X Genomics, Inc.District Court, D. Massachusetts · 2020
- Massachusetts Laborers' Health & Welfare Fund v. Boehringer Ingelheim Pharmaceuticals, Inc.District Court, D. Massachusetts · 2025
- Sage Chemical, Inc. v. Supernus Pharmaceuticals, Inc.District Court, D. Delaware · 2024
- ZERO TECHNOLOGIES, LLC v. THE CLOROX COMPANYDistrict Court, E.D. Pennsylvania · 2024